Stay updated on Fremanezumab in Preventing Chronic Migraine Clinical Trial
Sign up to get notified when there's something new on the Fremanezumab in Preventing Chronic Migraine Clinical Trial page.

Latest updates to the Fremanezumab in Preventing Chronic Migraine Clinical Trial page
- CheckyesterdayChange DetectedClinicalTrials.gov’s page footer now shows an updated software revision number, indicating a platform/version update rather than a modification to the underlying study record.SummaryDifference0.0%

- Check8 days agoChange DetectedThe study history shows an addition of Revision: v3.5.2 and a deletion of Revision: v3.5.0.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedRevision: v3.5.0 added. The previous revision v3.4.3 was removed.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision v3.4.3 was added to the history, replacing the previous v3.4.2.SummaryDifference0.0%

- Check73 days agoChange DetectedAdded revision v3.4.2. Removed the funding-status notice and the earlier revision v3.4.1.SummaryDifference0.3%

- Check80 days agoChange DetectedAdded a site-wide notice about government funding status and updated the page revision to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Fremanezumab in Preventing Chronic Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fremanezumab in Preventing Chronic Migraine Clinical Trial page.